Jushi (OTCMKTS:JUSHF – Get Free Report) is one of 55 public companies in the “Medicinals & botanicals” industry, but how does it weigh in compared to its rivals? We will compare Jushi to similar companies based on the strength of its analyst recommendations, risk, institutional ownership, dividends, valuation, earnings and profitability.
Insider & Institutional Ownership
21.7% of Jushi shares are held by institutional investors. Comparatively, 16.1% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 21.0% of Jushi shares are held by insiders. Comparatively, 22.4% of shares of all “Medicinals & botanicals” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of recent ratings and price targets for Jushi and its rivals, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Jushi | 0 | 2 | 0 | 0 | 2.00 |
Jushi Competitors | 246 | 546 | 920 | 66 | 2.45 |
Earnings and Valuation
This table compares Jushi and its rivals gross revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Jushi | $269.45 million | -$65.10 million | -2.03 |
Jushi Competitors | $298.06 million | -$154.30 million | -10.35 |
Jushi’s rivals have higher revenue, but lower earnings than Jushi. Jushi is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Profitability
This table compares Jushi and its rivals’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Jushi | -24.16% | -320.66% | -10.31% |
Jushi Competitors | -45.53% | -60.43% | -9.08% |
Risk & Volatility
Jushi has a beta of -0.16, meaning that its stock price is 116% less volatile than the S&P 500. Comparatively, Jushi’s rivals have a beta of 1.36, meaning that their average stock price is 36% more volatile than the S&P 500.
Summary
Jushi rivals beat Jushi on 9 of the 13 factors compared.
About Jushi
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabis dry flower, vaporizer forms of cannabis, edibles, cannabis oil in capsules, tinctures, cannabis in topical products, and other cannabis products, as well as vape cartridges, disposables, and concentrates under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. In addition, it operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. The company is headquartered in Boca Raton, Florida.
Receive News & Ratings for Jushi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jushi and related companies with MarketBeat.com's FREE daily email newsletter.